Symposia: Outcomes Research—Myeloid Malignancies
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, Biological therapies, AML, MDS, adult, Clinical Practice (Health Services and Quality), epidemiology, elderly, Clinical Research, health outcomes research, Diversity, Equity, and Inclusion (DEI) , Chronic Myeloid Malignancies, Diseases, Therapies, real-world evidence, Adverse Events, registries, Myeloid Malignancies, survivorship, Study Population, Human, Transplantation
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, Biological therapies, AML, MDS, adult, Clinical Practice (Health Services and Quality), epidemiology, elderly, Clinical Research, health outcomes research, Diversity, Equity, and Inclusion (DEI) , Chronic Myeloid Malignancies, Diseases, Therapies, real-world evidence, Adverse Events, registries, Myeloid Malignancies, survivorship, Study Population, Human, Transplantation
Saturday, December 10, 2022: 2:00 PM-3:30 PM
220-222
(Ernest N. Morial Convention Center)
Moderators:
Rebecca L. Olin, MD, University of California, San Francisco
and
Eduardo M Rego, MD, PhD, University of São Paulo
Disclosures:
Olin: Cellectis: Other: NA; Astellas: Consultancy; Actinium: Consultancy; Abbvie: Consultancy.
Studies focusing real-world outcomes, healthcare services utilization and evaluation of risk in myeloid malignancies
2:00 PM
2:15 PM
2:30 PM
3:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH